Form 4: Quest Diagnostics SVP Patrick Plewman Reports Acquisition of Common Stock

Patrick Plewman, SVP at Quest Diagnostics, reports acquiring 69 shares of common stock through a dividend reinvestment plan and stock purchase plan.

Summary

• Patrick Plewman, a Senior Vice President at Quest Diagnostics, filed a Form 4 with the SEC.
• The form reports changes in beneficial ownership of Quest Diagnostics' common stock.
• On April 22, 2024, Plewman acquired 69 shares of common stock at a price of $126.245 per share through a dividend reinvestment plan.
• The form also includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
• Following the reported transactions, Plewman beneficially owns 16,062 shares of Quest Diagnostics' common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing reporting stock transactions, indicating a neutral sentiment.

Positives

• The reporting person increased their holdings in the company.

Industry Context

Form 4 filings are standard practice for company insiders to report changes in their ownership of company stock, providing transparency to investors.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates